Liver fibrosis and methods of assessment in light of chronic hepatitis delta
Закрыть
Conţinutul numărului revistei
Articolul precedent
Articolul urmator
342 5
Ultima descărcare din IBN:
2023-10-31 16:08
Căutarea după subiecte
similare conform CZU
616.36-004-02:616.36-002.2 (1)
Заболевания пищеварительной системы. Болезнь пищеварительного тракта (1732)
SM ISO690:2012
TAHIR WANI, Suhaib, ŢURCANU, Adela. Liver fibrosis and methods of assessment in light of chronic hepatitis delta. In: Arta Medica , 2021, nr. 1(78), pp. 53-58. ISSN 1810-1852. DOI: https://doi.org/10.5281/zenodo.4744452
EXPORT metadate:
Google Scholar
Crossref
CERIF

DataCite
Dublin Core
Arta Medica
Numărul 1(78) / 2021 / ISSN 1810-1852 /ISSNe 1810-1879

Liver fibrosis and methods of assessment in light of chronic hepatitis delta

DOI:https://doi.org/10.5281/zenodo.4744452
CZU: 616.36-004-02:616.36-002.2

Pag. 53-58

Tahir Wani Suhaib, Ţurcanu Adela
 
”Nicolae Testemițanu” State University of Medicine and Pharmacy
 
 
Disponibil în IBN: 23 mai 2021


Rezumat

Objectives. Liver fibrosis is a wound healing response that causes accumulation of collagen and other extracellular proteins after an insult caused to liver or during a chronic liver disease. When left untreated, it may result in liver cirrhosis and portal hypertension, hepatic encephalopathy, liver failure, and an increased risk of hepatocellular carcinoma, which can ultimately cause organ failure and death. Material and methods. Research articles from various sources were reviewed and a sum of different methods for non-invasive assessment liver assessment were picked to put forth a constructive composite review. Results. Only two scores i.e., Baseline-event-anticipation score and Delta Fibrosis Score were found to show applicability in assessing liver fibrosis caused by chronic hepatitis delta virus infection, however, further studies are required. Conclusion. Although a few non-invasive scoring methods, for assessment of liver fibrosis caused due to chronic hepatitis delta virus infection, have been put forth over the past few years, enough research and data collection is yet to be done for proper validation and use. Even though liver biopsy still remains the gold standard for assessing liver fibrosis, its invasive nature does not make it feasible for all patients.

Cuvinte-cheie
fibrosis, HDV, kupffer cells, non-invasive assessment